| Ackermann DM, Smit AK, Janda M, van Kemenade CH, Dieng M, Morton RL, Turner RM, Cust AE, Irwig L, Hersch JK, Guitera P, Soyer HP, Mar V, Saw RPM, Low D, Low C, Drabarek D, Espinoza D, Emery J, Murchie P, Thompson JF, Scolyer RA, Azzi A, Lilleyman A, Bell KJL. Can patient-led surveillance detect subsequent new primary or recurrent melanomas and reduce the need for routinely scheduled follow-up? A protocol for the MEL-SELF randomised controlled trial. Trials 22, no. 1 (May 4 2021): 324, doi:10.1186/s13063-021-05231-7. |
| Aivazian K, Ahmed T, El Sharouni MA, Stretch JR, Saw RPM, Spillane AJ, Shannon KF, Ch'ng S, Nieweg OE, Thompson JF, Lo SN, Scolyer RA. Correction to: Histological regression in melanoma: impact on sentinel lymph node status and survival. Mod Pathol, (Aug 4 2021), doi:10.1038/s41379-021-00878-8. |
| Aivazian K, Ahmed T, El Sharouni M-A, Stretch JR, Saw RPM, Spillane AJ, Shannon KF, Ch'ng S, Nieweg OE, Thompson JF, Lo SN, Scolyer RA. Histological regression in melanoma: impact on sentinel lymph node status and survival. Modern Pathology, (Jul 10 2021), doi:10.1038/s41379-021-00870-2. |
| Berger D, van den Berg N, van der Noort V, van der Hiel B, Valdés Olmos RA, Buckle TA, KleinJan G, Brouwer OR, Vermeeren L, Karakullukçu B, van den Brekel M, van der Wiel B, Nieweg OE, Balm A, van Leeuwen FE, Klop M. Technological (R)Evolution Leads to Detection of More Sentinel Nodes in Patients with Melanoma in the Head and Neck Region. J Nucl Med, (Feb 26 2021), doi:10.2967/jnumed.120.246819. |
| Blood Z, Tran A, Caleo L, Saw R, Dieng M, Shackleton M, Soyer HP, Arnold C, Mann GJ, Morton RL. Implementation of patient-reported outcome measures and patient-reported experience measures in melanoma clinical quality registries: a systematic review. BMJ Open 11, no. 2 (Feb 11 2021): e040751, doi:10.1136/bmjopen-2020-040751. |
| Broman KK, Hughes T, Dossett L, Sun J, Kirichenko D, Carr MJ, Sharma A, Bartlett EK, Nijhuis AAG, Thompson JF, Hieken TJ, Kottschade L, Downs J, Gyorki DE, Stahlie E, van Akkooi A, Ollila DW, Frank J, Song Y, Karakousis G, Moncrieff M, Nobes J, Vetto J, Han D, Farma JM, Deneve JL, Fleming MD, Perez MC, Lowe MC, Olofsson Bagge R, Mattsson J, Lee AY, Berman RS, Chai H, Kroon HM, Teras J, Teras RM, Farrow NE, Beasley G, Hui JYC, Been L, Kruijff S, Kim Y, Naqvi SMH, Sarnaik AA, Sondak VK, Zager JS. Active surveillance of patients who have sentinel node positive melanoma: An international, multi-institution evaluation of adoption and early outcomes after the Multicenter Selective Lymphadenectomy trial II (MSLT-2). Cancer (Apr 2021), doi:https://doi.org/10.1002/cncr.33483. |
| Chakera A, Sibbesen E, Schoedt M, Hölmich LR, Zerahn B, Thompson JF. The worse survival outcomes reported for melanoma patients having sentinel node biopsy after lymphoscintigraphy the previous day do not appear to be due to overnight migration of Tc99m-nanocolloid tracer. European Journal of Surgical Oncology, (Mar 17 2021), doi:https://doi.org/10.1016/j.ejso.2021.03.241. |
| Chakraborty A, Perez M, Mohammed NBB, Wells M, Wilmott JS, Thompson JF, Haslam SM, Wang W, Scolyer RA, Murphy GF, Dimitroff CJ. Abstract 2609: Hypoxia-mediated downregulation of GCNT2/I-antigen in metastatic melanoma accelerates disease progression and mortality. Cancer Research 81, no. 13 Supplement (Jul 01 2021): 2609-09, doi:10.1158/1538-7445.am2021-2609. |
| Ch'ng S, Scolyer RA, Thompson JF. ASO Author Reflections: Surgical Resection May Improve the Outcome for Patients with Residual Metastatic Melanoma When Modern Systemic Therapies Have Not Achieved Complete Disease Control. Ann Surg Oncol 28, no. 11 (Aug 9 2021): 6124-25, doi:10.1245/s10434-021-10514-z. |
| Ch'ng S, Uyulmaz S, Carlino MS, Pennington TE, Shannon KF, Rtshiladze M, Stretch JR, Nieweg OE, Varey AHR, Hsiao E, Kapoor R, Pires da Silva I, Lo SN, Spillane AJ, Scolyer RA, Long GV, Hong AM, Saw RPM, Thompson JF, Menzies AM. Re-defining the role of surgery in the management of patients with oligometastatic stage IV melanoma in the era of effective systemic therapies. Eur J Cancer 153, (Jun 11 2021): 8-15, doi:10.1016/j.ejca.2021.04.037. |
| Dawson R, Phung D, Every J, Gunawardena D, Low TH, Ch'ng S, Clark J, Wykes J, Palme CE. Tracheostomy in free-flap reconstruction of the oral cavity: can it be avoided? A cohort study of 187 patients. ANZ J Surg 91, no. 6 (Jun 2021): 1246-50, doi:10.1111/ans.16762. |
| Dessinioti C, Geller AC, Stergiopoulou A, Dimou N, Lo S, Keim U, Gershenwald JE, Haydu LE, Dummer R, Mangana J, Hauschild A, Egberts F, Vieira R, Brinca A, Zalaudek I, Deinlein T, Evangelou E, Thompson JF, Scolyer RA, Peris K, Garbe C, Stratigos AJ. A multicenter study of nevus-associated melanoma versus de novo melanoma, tumor thickness and body site differences. Br J Dermatol, (Jan 16 2021), doi:10.1111/bjd.19819. |
| Dieng M, Lord SJ, Nieweg OE, Saw RPM, Einstein AJ, Nijhuis AAG, Turner RM, Thompson JF, Morton RL. Reply to: CT and PET/CT Surveillance in Stage IIIA-D Melanoma Results in More False-Positive Than True-Positive Findings and Should Not be Routinely Recommended, by Nicholas Taylor et al. Annals of Surgical Oncology, (May 02 2021), doi:10.1245/s10434-021-09821-2. |
| El Sharouni MA, Ahmed T, Varey AHR, Elias SG, Witkamp AJ, Sigurdsson V, Suijkerbuijk KPM, van Diest PJ, Scolyer RA, van Gils CH, Thompson JF, Blokx WAM, Lo SN. Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas. J Clin Oncol, (Feb 18 2021): Jco2002446, doi:10.1200/jco.20.02446. |
| El Sharouni MA, Varey AHR, Witkamp AJ, Ahmed T, Sigurdsson V, van Diest PJ, Scolyer RA, Thompson JF, Lo SN, van Gils CH. Predicting sentinel node positivity in melanoma patients: external validation of a risk-prediction calculator (the MIA nomogram) using a large European population-based patient cohort. British Journal of Dermatology (Mar 03 2021), doi:https://doi.org/10.1111/bjd.19895. |
| Every J, Subramaniam N, Dawson R, Ch'ng S, Low TH, Palme CE, Clark J, Wykes J. Microvascular reconstruction of head and neck defects in the elderly. ANZ J Surg 91, no. 5 (May 2021): 969-74, doi:10.1111/ans.16771. |
| Friedman EB, Scolyer RA, Williams GJ, Thompson JF. Melanoma In Situ: A Critical Review and Re-Evaluation of Current Excision Margin Recommendations. Advances in Therapy, (May 28 2021), doi:10.1007/s12325-021-01783-x. |
| Gallagher SJ, Bailey T, Rawson RV, Mahar AM, Thompson JF, Long GV, Wilmott JS, Scolyer RA. Melanoma with osseous or chondroid differentiation: a report of eight cases including SATB2 expression and mutation analysis. Pathology, (June 02 2021), doi:https://doi.org/10.1016/j.pathol.2021.02.012. |
| Garg M, Couturier D-L, Nsengimana J, Fonseca NA, Wongchenko M, Yan Y, Lauss M, Jönsson GB, Newton-Bishop J, Parkinson C, Middleton MR, Bishop DT, McDonald S, Stefanos N, Tadross J, Vergara IA, Lo S, Newell F, Wilmott JS, Thompson JF, Long GV, Scolyer RA, Corrie P, Adams DJ, Brazma A, Rabbie R. Tumour gene expression signature in primary melanoma predicts long-term outcomes. Nature Communications 12, no. 1 (Feb 18 2021): 1137, doi:10.1038/s41467-021-21207-2. |
| Gherardin NA, Waldeck K, Caneborg A, Martelotto LG, Balachander S, Zethoven M, Petrone PM, Pattison A, Wilmott JS, Quiñones-Parra SM, Rossello F, Posner A, Wong A, Weppler AM, Shannon KF, Hong A, Ferguson PM, Jakrot V, Raleigh J, Hatzimihalis A, Neeson PJ, Deleso P, Johnston M, Chua M, Becker JC, Sandhu S, McArthur GA, Gill AJ, Scolyer RA, Hicks RJ, Godfrey DI, Tothill RW. γδ T cells in Merkel cell carcinomas have a proinflammatory profile prognostic of patient survival. Cancer Immunology Research, (Feb 2021): canimm.0817.2020, doi:10.1158/2326-6066.cir-20-0817. |
| Gide TN, Pires da Silva I, Quek C, Ferguson PM, Batten M, Shang P, Ahmed T, Menzies AM, Carlino MS, Saw RPM, Thompson JF, Scolyer RA, Long GV, Wilmott JS. Clinical and Molecular Heterogeneity in Patients with Innate Resistance to Anti-PD-1 +/- Anti-CTLA-4 Immunotherapy in Metastatic Melanoma Reveals Distinct Therapeutic Targets. Cancers (Basel) 13, no. 13 (Jun 25 2021), doi:10.3390/cancers13133186. |
| Gide TN, Silva IP, Quek C, Ferguson PM, Batten M, Shang P, Ahmed T, Menzies AM, Carlino MS, Saw RPM, Thompson JF, Wilmott JS, Scolyer RA, Long GV. Analysis of clinical and molecular profiles of patients with innate resistance to ANTI-PD-1 +/- ANTI-CTLA-4 immunotherapy in metastatic melanoma. Pathology 53, (Jul 01 2021), doi:https://doi.org/10.1016/j.pathol.2021.05.087. |
| Guitera P, Waddell A, Paton E, Fogarty GB, Hong A, Scolyer RA, Stretch JR, O'Donnell BA, Pellacani G. A practical guide on the use of imiquimod cream to treat lentigo maligna. Australas J Dermatol, (Sep 16 2021), doi:10.1111/ajd.13720. |
| Güvenç C, Antoranz A, Szumera-Ciećkiewicz A, Teterycz PP, Rutkowski PR, Rawson RV, Scolyer RA, Thompson JF, Newton-Bishop J, Stas M, Boecxstaens V, Bechter O, Vercauteren J, Garmyn M, van den Oord J, Bosisio FM. Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick Melanomas. International Journal of Molecular Sciences 22, no. 19 (Sep 29 2021): 10568. |
| Gyorki D, Moncrieff MD, Saw RP, Spillane AJ, Bagge RO, Wright F, Dancey J, Mammen JM, Paton E, Williams N, Seminara D, Eguchi J, Henderson MA. Melanoma Margins Trial (MelMarT-II): A Framework for Global Recruitment to a Large Multicentre Multinational Randomised Controlled Trial. Annals of Surgical Oncology 28, no. SUPPL 1 (Feb 2021): S105-S05. |
| Haefliger S, Guitera P, Melhoranse Gouveia B, Colebatch AJ, Scolyer RA, Rtshiladze M, Martin LK. Case report of a challenging medium-sized congenital melanocytic nevus (CMN): Highlighting a role for reflectance confocal microscopy (RCM) for evaluating changing CMN in children. Pediatric Dermatology (Nov 04 2021), doi:https://doi.org/10.1111/pde.14846. |
| Hanna S, Lo SN, Saw RPM. Surgical excision margins in primary cutaneous melanoma: A systematic review and meta-analysis. European Journal of Surgical Oncology, (Mar 03 2021), doi:https://doi.org/10.1016/j.ejso.2021.02.025. |
| Hong AM, Waldstein C, Shivalingam B, Carlino MS, Atkinson V, Kefford RF, McArthur GA, Menzies AM, Thompson JF, Long GV. Management of melanoma brain metastases: Evidence-based clinical practice guidelines by Cancer Council Australia. European Journal of Cancer 142, (Jan 2021): 10-17, doi:10.1016/j.ejca.2020.10.013. |
| Hughes TM, Williams GJ, Gyorki DE, Kelly JW, Stretch JR, Varey AHR, Hong AM, Scolyer RA, Thompson JF. Desmoplastic Melanoma: A review of its pathology and clinical behaviour, and of management recommendations in published guidelines. J Eur Acad Dermatol Venereol, (Feb 5 2021), doi:10.1111/jdv.17154. |
| Jackett LA, Satgunaseelan L, Roper E, Lo SN, Thompson JF, Scolyer RA. Residual melanoma in wide local excision specimens after 'complete' excision of primary cutaneous in situ and invasive melanomas. Pathology, (Aug 12 2021), doi:10.1016/j.pathol.2021.05.094. |
| Khushalani NI, Truong T-G, Thompson JF. Current Challenges in Access to Melanoma Care: A Multidisciplinary Perspective. American Society of Clinical Oncology Educational Book, no. 41 (May 27 2021): e295-e303, doi:10.1200/edbk_320301. |
| Li AT, Maw AM, Hsiao E, Ch'ng S, Long GV, Shannon KF, Morrison EJ. Bilateral facial neuritis associated with dabrafenib and trametinib after failure of neoadjuvant immunotherapy for stage III melanoma. ANZ J Surg, (Jun 14 2021), doi:10.1111/ans.16992. |
| Li AT, Vakharia K, Lo SN, Varey AHR, Carlino MS, Saw RPM, Shannon KF, Howle JR, Pennington TE, Stretch JR, Nieweg OE, Spillane AJ, Long GV, Menzies AM, Scolyer RA, Thompson JF, Ch'ng S. Survival Outcomes of Salvage Metastasectomy After Failure of Modern-Era Systemic Therapy for Melanoma. Annals of Surgical Oncology, (Aug 04 2021), doi:10.1245/s10434-021-10489-x. |
| Li AT, Vakharia K, Lo SN, Varey AHR, Carlino MS, Saw RPM, Shannon KF, Howle JR, Pennington TE, Stretch JR, Nieweg OE, Spillane AJ, Long GV, Menzies AM, Scolyer RA, Thompson JF, Ch'ng S. ASO Visual Abstract: Survival Outcomes of Salvage Metastasectomy after Failure of Modern-Era Systemic Therapy for Melanoma. Ann Surg Oncol, (Aug 10 2021), doi:10.1245/s10434-021-10529-6. |
| Liyanage U, MacGregor S, Bishop DT, Shi J, An J, Ong JS, Han X, Scolyer RA, Martin NG, Medland SE, Byrne EM, Green AC, Saw RPM, Thompson JF, Stretch J, Spillane A, Jiang Y, Tian C, Gordon SG, Duffy DL, Olsen CM, Whiteman DC, Long GV, Iles MM, Landi MT, Law MH. Multi-trait genetic analysis identifies auto-immune loci associated with cutaneous melanoma. Journal of Investigative Dermatology, (Nov 20 2021), doi:https://doi.org/10.1016/j.jid.2021.08.449. |
| Lo SN, Thompson JF. Adaptive designs for clinical trials have potential advantages, but statistical challenges lurk! British Journal of Dermatology (Nov 22 2021), doi:https://doi.org/10.1111/bjd.20828. |
| Mangantig E, MacGregor S, Iles MM, Scolyer RA, Cust AE, Hayward NK, Montgomery GW, Duffy DL, Thompson JF, Henders A, Bowdler L, Rowe C, Cadby G, Mann GJ, Whiteman DC, Long GV, Ward SV, Khosrotehrani K, Barrett JH, Law MH. Germline variants are associated with increased primary melanoma tumor thickness at diagnosis. Hum Mol Genet 29, no. 21 (Jan 6 2021): 3578-87, doi:10.1093/hmg/ddaa222. |
| Menzies AM, Amaria RN, Rozeman EA, Huang AC, Tetzlaff MT, van de Wiel BA, Lo S, Tarhini AA, Burton EM, Pennington TE, Saw RPM, Xu X, Karakousis GC, Ascierto PA, Spillane AJ, van Akkooi ACJ, Davies MA, Mitchell TC, Tawbi HA, Scolyer RA, Wargo JA, Blank CU, Long GV. Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC). Nat Med, (Feb 8 2021), doi:10.1038/s41591-020-01188-3. |
| Mooney CP, Clark JR, Shannon K, Palme CE, Ebrahimi A, Gao K, Ch'ng S, Elliott M, Gupta R, Low TH. The significance of regional metastasis location in head and neck cutaneous squamous cell carcinoma. Head Neck 43, no. 9 (Sep 2021): 2705-11, doi:10.1002/hed.26744. |
| Morrison F, Nieweg OE. Fellow profile: Dr. Omgo E. Nieweg. a winding path to surgery leads to innovation in cancer research. Surg News 2021, Oct 12 2021, 39. |
| Nieweg OE, Nieweg-Kroes J. Ter gelegenheid van het afscheid als chirurg van Jaap de Vries. In Liber amicorum Jaap de Vries, edited by L. Jansen, A. Prozée and P. Nijnuis, 2021. |
| Owen CN, Bai X, Quah T, Lo S, Allayous C, Callaghan S, Martínez-Vila C, Wallace R, Bhave P, Reijers I, Thompson N, Vanella V, Gerard C, Aspelagh S, Labianca A, Khattak A, Mandala N, Xu W, Neyns B, Michielin O, Blank CU, Welsh SJ, Haydon A, Sandhu S, Mangana J, McQuade J, Ascierto P, Zimmer L, Johnson DB, Arance A, Lorigan P, Lebbé C, Carlino MS, Sullivan R, Long* GV, Menzies* AM. Delayed immune-related adverse events (irAE) on anti-PD1-based therapy in melanoma. Annals of Oncology, (Mar 30 2021), doi:https://doi.org/10.1016/j.annonc.2021.03.204. |
| Patrinely JR, Jr, Johnson R, Lawless AR, Bhave P, Sawyers A, Dimitrova M, Yeoh HL, Palmeri M, Ye F, Fan R, Davis EJ, Rapisuwon S, Long GV, Haydon A, Osman I, Mehnert JM, Carlino MS, Sullivan RJ, Menzies AM, Johnson DB. Chronic Immune-Related Adverse Events Following Adjuvant Anti-PD-1 Therapy for High-risk Resected Melanoma. JAMA Oncology, (Mar 25 2021), doi:10.1001/jamaoncol.2021.0051. |
| Quek C, Silva IP, Al-Eryani G, Mayer A, Bartonicek N, Harvey K, Buckley C, Braubach O, Thompson JF, Stretch JR, Saw RPM, Shannon KF, Menzies AM, Scolyer RA, Long GV, Swarbrick A, Wilmott JS. Abstract 2761: CODEX highly multiplex image mapping to CITEseq datasets reveal the spatial dynamics of the TME during the development of acquired resistant in immunotherapy treated melanoma. Cancer Research 81, no. 13 Supplement (Jul 01 2021): 2761-61, doi:10.1158/1538-7445.am2021-2761. |
| Rawson RV, Adhikari C, Bierman C, Lo SN, Shklovskaya E, Rozeman EA, Menzies AM, van Akkooi ACJ, Shannon KF, Gonzalez M, Guminski AD, Tetzlaff MT, Stretch JR, Eriksson H, van Thienen JV, Wouters MW, Haanen J, Klop WMC, Zuur CL, van Houdt WJ, Nieweg OE, Ch'ng S, Rizos H, Saw RPM, Spillane AJ, Wilmott JS, Blank CU, Long GV, van de Wiel BA, Scolyer RA. Pathological response and tumour bed histopathological features correlate with survival following neoadjuvant immunotherapy in stage III melanoma. Ann Oncol 32, no. 6 (Jun 2021): 766-77, doi:10.1016/j.annonc.2021.03.006. |
| Read RL, Thompson JF. The role of regional chemotherapy for advanced limb melanoma in the era of potentially effective systemic therapies. Melanoma Research Publish Ahead of Print, (May 25 2021), doi:10.1097/cmr.0000000000000740. |
| Rozeman EA, Hoefsmit EP, Reijers ILM, Saw RPM, Versluis JM, Krijgsman O, Dimitriadis P, Sikorska K, van de Wiel BA, Eriksson H, Gonzalez M, Torres Acosta A, Grijpink-Ongering LG, Shannon K, Haanen JBAG, Stretch J, Ch'ng S, Nieweg OE, Mallo HA, Adriaansz S, Kerkhoven RM, Cornelissen S, Broeks A, Klop WMC, Zuur CL, van Houdt WJ, Peeper DS, Spillane AJ, van Akkooi ACJ, Scolyer RA, Schumacher TNM, Menzies AM, Long GV, Blank CU. Survival and biomarker analyses from the OpACIN-neo and OpACIN neoadjuvant immunotherapy trials in stage III melanoma. Nature Medicine, (Feb 08 2021), doi:10.1038/s41591-020-01211-7. |
| Scolyer RA, El Sharouni M-A, Thompson JF. Characterizing the Clinical Implications of Histologic Regression in Melanoma Requires Clear Diagnostic Criteria That Are Consistently Applied-Reply. JAMA Dermatology, (Jun 30 2021), doi:10.1001/jamadermatol.2021.1497. |
| Smith AL, Watts CG, Robinson S, Schmid H, Goumas C, Mar VJ, Thompson JF, Rapport F, Cust AE. Knowledge and attitudes of Australian dermatologists towards sentinel lymph node biopsy for melanoma: a mixed methods study. Australas J Dermatol 62, no. 2 (May 2021): 168-76, doi:10.1111/ajd.13518. |
| Smithers BM, Saw RPM, Gyorki DE, Martin RCW, Atkinson V, Haydon A, Roberts-Thomson R, Thompson JF. Contemporary management of locoregionally advanced melanoma in Australia and New Zealand and the role of adjuvant systemic therapy. ANZ Journal of Surgery 91, no. S2 (Jul 20 2021): 3-13, doi:https://doi.org/10.1111/ans.17051. |
| Thompson JF. In Sentinel Node-Positive Melanoma Patients, Does Omission of Completion Lymph Node Dissection Make More Intensive Follow-Up Necessary, and Does Adjuvant Systemic Therapy Permit Less Intensive Follow-Up? Annals of Surgical Oncology, (Aug 07 2021), doi:10.1245/s10434-021-10572-3. |
| Thompson JF, Haydu LE, Uren RF, Andtbacka RH, Zager JS, Beitsch PD, Agnese DM, Mozzillo N, Testori A, Bowles TL, Hoekstra HJ, Kelley MC, Sussman J, Schneebaum S, Smithers BM, McKinnon G, Hsueh E, Jacobs L, Schultz E, Reintgen D, Kane JM, Friedman EB, Wang H, Van Kreuningen L, Schiller V, Elashoff DA, Elashoff R, Cochran AJ, Stern S, Faries MB. Preoperative Ultrasound Assessment of Regional Lymph Nodes in Melanoma Patients Does not Provide Reliable Nodal Staging: Results From a Large Multicenter Trial. Ann Surg 273, no. 4 (Apr 1 2021): 814-20, doi:10.1097/sla.0000000000003405. |
| Thompson JF, Saw RPM, Dalton JM, Stretch JR, Spillane AJ, Osborne NS, Williams GJ, Lo SN. Treatment of in-transit melanoma metastases using intralesional PV-10. Melanoma Res, (Mar 18 2021), doi:10.1097/cmr.0000000000000729. |
| Turner RM, Dieng M, Khanna N, Nguyen M, Zeng J, Nijhuis AAG, Nieweg OE, Einstein AJ, Emmett L, Lord SJ, Menzies AM, Thompson JF, Saw RPM, Morton RL. Performance of Long-Term CT and PET/CT Surveillance for Detection of Distant Recurrence in Patients with Resected Stage IIIA-D Melanoma. Ann Surg Oncol, (Jan 3 2021), doi:10.1245/s10434-020-09270-3. |
| Versluis JM, Reijers ILM, Rozeman EA, Menzies AM, van Akkooi ACJ, Wouters MW, Ch'ng S, Saw RPM, Scolyer RA, van de Wiel BA, Schilling B, Long GV, Blank CU. Neoadjuvant ipilimumab plus nivolumab in synchronous clinical stage III melanoma. Eur J Cancer 148, (May 2021): 51-57, doi:10.1016/j.ejca.2021.02.012. |
| Watts CG, McLoughlin K, Goumas C, van Kemenade CH, Aitken JF, Soyer HP, Fernandez Peñas P, Guitera P, Scolyer RA, Morton RL, Menzies SW, Caruana M, Kang YJ, Mann GJ, Chakera AH, Madronio CM, Armstrong BK, Thompson JF, Cust AE. Association Between Melanoma Detected During Routine Skin Checks and Mortality. JAMA Dermatology, (Nov 03 2021), doi:10.1001/jamadermatol.2021.3884. |
| Williams GJ, Webster AC, Thompson JF. Organ transplantation and outcomes in patients with a past history of melanoma: a systematic review and meta-analysis. Clin Transplant, (Mar 15 2021): e14287, doi:10.1111/ctr.14287. |
| Yung AE, Que MS, Lo S, Aggarwal S, Hong AM, Tin MM, Clark JR, Gupta R, Ch'ng S. Validation of the American Joint Committee on Cancer Staging in Squamous Cell Carcinoma of the Vermilion Lip. Ann Surg Oncol, (Jan 2 2021), doi:10.1245/s10434-020-09431-4. |
